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Abstract  24 
 The present research aimed to provide novel information regarding the antidiabetic mechanism 25 
of action of coffee silverskin extract (CSE) and its components chlorogenic acid (CGA) and caffeine 26 
(CF). Their effect on insulin secretion and biomarkers of oxidative stress in INS-1E cells in vitro 27 
cultured under physiological and stressed conditions were assessed. Under physiological conditions, 28 
CSE and pure CGA and CF did not affect cells´ oxidative status and viability. However, concentrations 29 
of CSE ≥ 1µg/mL and CGA ≥ 5 µM significantly increased (p < 0.05) the enzymatic activity of 30 
glutathione peroxidase (GPx).  Moreover, all concentrations of CSE (1-10 µg/mL) and the dose of 10 31 
µM of CGA, significantly stimulated (p < 0.05) insulin secretion in cells cultured in media containing 4 32 
and 10 mM of glucose. CSE (1µg/mL) and CGA (10µM) reinforced antioxidant defence and increased 33 
insulin secretion in response to glucose in beta cells stressed with streptozotocin (STZ). Since CGA 34 
concentration in CSE was of ≈ 0.1 nM it can be assumed that other antioxidants present in this 35 
particular extract may also contribute to the observed effect. In conclusion, here we provide evidence 36 
that CSE could be a new potential antidiabetic agent through its antioxidant actions and its ability to 37 
modulate insulin secretory function.  38 
 39 
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Highlights.  42 
 43 
- Coffee silverskin extract increases GPx activity  in INS-1E cells  44 
- Coffee silverskin extract increases insulin secretion in response to glucose in INS-1E cells  45 
- Coffee silverskin extract protects against STZ induced oxidative stress in INS-1E cells 46 
- Coffee silverskin extract may reduce risk of diabetes through pancreas protection   47 
48 
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1. Introduction 49 
 Type 2 diabetes (T2D) is a complex and multifactorial metabolic disorder characterized by persistent 50 
hyperglycaemia. Although T2D is caused by a deficiency in insulin secretion associated to decreased 51 
responsiveness of peripheral tissues to insulin, it is generally accepted that the inability of beta cells to 52 
secrete adequate amounts of insulin is primarily responsible for the development and progression of 53 
T2D (Marchetti, Dotta, Lauro, & Purrello, 2008). Hyperglycemia and the subsequent increase in 54 
oxidative stress that appears in diabetes mellitus have been largely implicated in the progressive 55 
dysfunction of pancreatic beta cells and in the development of diabetic complications (Bensellam, 56 
Laybutt, & Jonas, 2012). Micro- and macro-vascular complications of diabetes (blindness, kidney 57 
failure, heart disease, stroke and amputations) are the major causes of morbidity and mortality in human 58 
populations (IDF Diabetes Atlas Group, 2015). Currently, numerous antidiabetic drugs, including 59 
inducers of insulin secretion, are used as treatment of T2D. Nevertheless, all of them exhibit adverse 60 
side effects and, actually, even under treatment, beta cell dysfunction worsens driving to loss of 61 
glycemic control (Robertson, 2010). Therefore, there is a growing interest in the identification of 62 
naturally occurring antioxidant agents that may protect and improve beta cell mass and function since 63 
they may offer a natural alternative to reduce risk or treat diabetes and retard the onset of its 64 
complications. 65 
Coffee consumption, both caffeinated and decaffeinated, has been associated to a wide variety of 66 
health beneficial effects, in particular the reduced risk of T2D (Ding, Bhupathiraju, Chen, van Dam, & 67 
Hu, 2014; Jiang, Zhang, & Jiang, 2014). Coffee components, caffeine (CF) and chlorogenic acid (CGA), 68 
possess potential benefits on glucose homeostasis (Ludwig, Clifford, Lean, Ashiharad, & Crozier , 69 
2014). The effect of CGA and CF on glucose metabolism remains unclear (Akash, Rehman, & Chen, 70 
2014). The use of coffee by-products as natural source of compounds with putative health benefits such 71 
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as CGA, CF and dietary fiber among others has been proposed (del Castillo et al., 2013; del Castillo, 72 
Fernandez-Gomez, Martinez-Saez, Iriondo, & Mesa, 2015; Galanakis, Martinez-Saez, del Castillo, 73 
Francisco, & Mitropoulou, 2015). Glucoregulatory properties have been recently ascribed to a coffee 74 
silverskin extract (CSE) by-product of coffee roasting (del Castillo, Fernandez-Gomez, Ullate, & Mesa, 75 
2014). The antidiabetic effect of CSE has been associated to its capacity to inhibit enzymatic activity of 76 
α-glucosidase and lipase. CSE is also able to inhibit in vitro the formation of advanced glycation end-77 
products (AGEs) (Mesías et al., 2014; Fernandez-Gomez et al., 2015) which have been involved in the 78 
development of diabetes and its complications (Uribarri et al., 2015). However, up to date, the protective 79 
effect of CSE on the development and progression of diabetes and, particularly, on beta cell viability 80 
and function has not been evaluated.  81 
 Streptozotocin (STZ) is a potent DNA-methylating agent, which generates ROS that induce 82 
oxidative stress in pancreatic beta cells (Szkudelski, 2001). STZ has been used in beta cells to imitate 83 
the pathology of T2D and to evaluate the antidiabetic effect of novel compounds (Hong et al., 2013; 84 
Kim et al., 2013; Lee, Hang, Ko, Kang, & Jeon, 2013). The aim of the present study was to investigate 85 
the mechanism of action of CSE on the pathogenesis of diabetes using an in vitro model of beta cells, 86 
the INS-1E cells. To achieve this goal, the effect of CSE on redox status and insulin secretion in the 87 
pancreatic beta cells was evaluated. Likewise, its capacity to protect pancreatic beta cells against an 88 
oxidative damage induced by STZ was also examined. In addition, the main phenolic constituent CGA 89 
and the alkaloid CF were individually studied in order to determine their contribution to the beneficial 90 
effect of the CSE on the function of pancreatic beta cells. 91 
92 
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2. Material and Methods 93 
2.1. Materials and Chemicals 94 
CGA, CF, STZ, glutathione reductase (GR), reduced and oxidized glutathione (GSH and GSSG, 95 
respectively), NADH, NADPH, o-phthaldialdehyde (OPT), tert-butylhydroperoxide (t-BOOH), 96 
gentamicin, penicillin G, streptomycin and bovine serum albumin (fraction V) were purchased from 97 
Sigma Chemical (Madrid, Spain). The fluorescent probe 2′,7′-dichlorofluorescin diacetate (DCFH-DA) 98 
was from Molecular Probes (Eugene, OR). Cell culture dishes were from Falcon (Cajal, Madrid, Spain) 99 
and cell culture medium and fetal bovine serum from Lonza (Madrid, Spain). Bradford reagent was 100 
from BioRad Laboratories S.A. 101 
 102 
2.2. Preparation of coffee silverskin extract (CSE) 103 
 CS from the Arabica (Coffea arabica) species was provided by Fortaleza S.A. (Spain). 104 
According to the manufacturer, the weight portion of CS represents 0.6 % of the roasted beans. Arabica 105 
CSE was prepared by aqueous extraction according to the procedure patented by del Castillo et al. 106 
(2013). Briefly, 50 mL of boiling water was added to 2.5 g of CS. The mixture was stirred at 250 rpm 107 
for 10 min, filtered by Whatman paper no. 4 and the filtrate was freeze dried. The powdered extracts 108 
were stored in dark and dry place until analysis. Concentrations of the bioactive compounds were 109 
determined by a capillary electrophoresis and UV-Vis detection, and a detailed description of this CSE 110 
is given elsewhere (Mesías et al., 2014). Accordingly, the amounts of CGAs and CF present in the CSE 111 
were 11.18 mg/g and 30.26 mg/g, respectively.  112 
  113 
2.3. Cell culture and treatments 114 
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Rat insulinoma cell line, INS-1E, was kindly provided by Dr. Mario Vallejo of "Alberto Sols" 115 
Biomedical Research Institute CSIC, Madrid, Spain. INS-1E cells were maintained in a humidified 116 
incubator containing 5 % CO2 and 95 % air at 37 ºC. They were grown in RPMI-1640 medium with 11 117 
mM glucose, supplemented with 10 % fetal bovine serum (FBS), 1 % Hepes, 1 mM sodium pyruvate, 118 
50 μM betamercaptoethanol and 1 % of the following antibiotics: gentamicin, penicillin and 119 
streptomycin. 120 
For the treatments with the different compounds, concentrations of CSE (1, 5 and 10 μg/mL), 121 
CGA (1, 5 and 10 μM) and CF (1, 5 and 10 μM) diluted in RPMI-1640 culture medium and filtered 122 
through a 0.2-μm membrane were added to cell plates during 20 h. For STZ treatment, STZ was 123 
dissolved in 0.1 M citrate buffer (pH 4.5) and added to cell plates during different times (3-18 h) and 124 
concentrations ranging from 1 to 5 mM.  125 
 126 
2.4. Evaluation of cell viability and production of reactive oxygen species (ROS) 127 
Cell viability was determined by the crystal violet assay. INS-1E cells were seeded at low 128 
density (2 x 105 cells per well) in 24-well plates. After the different treatments, cells were incubated 129 
with crystal violet (0.2 % in ethanol) for 20 min. Plates were rinsed with distilled water, allowed to dry, 130 
and 1 % sodium dodecyl sulphate (SDS) was added. The absorbance of each well was measured using 131 
a microplate reader at 570 nm (Bio-Tek, Winooski, VT, USA).  132 
Cellular ROS were quantified by the DCFH assay using a microplate reader (Wang & Joseph, 133 
1999).. For the assay, cells were plated in 24-multiwells and incubated with the different treatments. 134 
After that, 10 µM DCFH was added to the wells for 30 min at 37 ºC. After being oxidized by 135 
intracellular oxidants, DCFH will become dichlorofluorescein (DCF) and emit fluorescence. ROS 136 
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generation was evaluated in a fluorescent microplate reader at an excitation wavelength of 485 nm and 137 
an emission wavelength of 530 nm (Bio-Tek, Winooski, VT, USA). 138 
 139 
2.5. Glucose-stimulated insulin secretion (GSIS) and content 140 
After the different treatments, INS-1E cells were washed and placed in Krebs–Ringer 141 
bicarbonate buffer (KRB: 115 mM NaCl, 24 mM NaHCO3, 5 mM KCl, 1 mM MgCl2 6H2O, 1mM 142 
CaCl2 2H2O) supplemented with 5 mg/mL BSA for a quiescent period of two hours. Next, cells were 143 
incubated for 90 min in KRB containing 4 or 10 mM glucose and the different concentrations of CSE, 144 
CGA and CF. GSIS was evaluated in the medium by an enzyme-linked immunosorbent assay (ELISA) 145 
kit (Mercodia, Uppsala, Sweden).  146 
For cellular insulin content measurement, treated cells were lysed at 4 ºC in a buffer containing 147 
25 mM HEPES (pH 7.5), 0.2 mM EDTA, 0.1 % Triton X-100, 200 mM ß-glycerolphosphate, 0.1 mM 148 
Na3VO4, 2 µg/mL leupeptin, and 1 mM phenylmethylsulphonyl fluoride (PMSF). The supernatants 149 
were collected and assayed for insulin content by the ELISA kit (Mercodia, Uppsala, Sweden).  150 
 151 
2.6. Determination of glutathione peroxidase (GPx) and glutathione reductase (GR) activities  152 
Treated INS-1E cells were collected in PBS and centrifuged at low speed (300×g) for 5 min to 153 
pellet cells to assay the activities of GPx and GR. Cell pellets were resuspended in 20 mM Tris 154 
containing 5 mM EDTA and 0.5 mM beta-mercaptoethanol, sonicated and centrifuged at 3000×g for 155 
15 min. Enzyme activities were measured in the supernatants. Determination of GPx activity was based 156 
on the oxidation of GSH by GPx, using t-BOOH as a substrate, coupled to the disappearance of 157 
NADPH by GR. GR activity was determined by following the decrease of the absorbance due to the 158 
oxidation of NADPH utilized in the reduction of GSSG. The methods have been previously described 159 
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(Rodríguez-Ramiro, Martín, Ramos, Bravo, & Goya, 2011). Protein was measured by the Bradford 160 
reagent. 161 
 162 
2.7. Determination of reduced glutathione (GSH) 163 
The concentration of GSH was evaluated by a fluorometric assay previously described 164 
(Rodríguez-Ramiro, Martín, Ramos, Bravo, & Goya, 2011). The method takes advantage of the 165 
reaction of GSH with OPT at pH 8.0. After the different treatments, the culture medium was removed 166 
and cells were detached and homogenised by ultrasound with 5 % trichloroacetic acid containing 2 mM 167 
EDTA. Following centrifugation of INS-1E beta cells homogenates for 30 min at 3.000 rpm, 50 µL of 168 
the clear supernatant were transferred to a 96-multiwell plate for the assay. Fluorescence was measured 169 
at an emission wavelength of 460 nm and an excitation wavelength of 340 nm. The results were 170 
interpolated in a GSH standard curve (5 – 1000 ng) and expressed as nmol GSH/mg protein, which was 171 
determined by the Bradford reagent.  172 
 173 
2.8. Determination of carbonyl groups 174 
 Protein oxidation was measured as carbonyl groups content according to a published method 175 
(Granado-Serrano, Martín, Bravo, Goya, & Ramos, 2009). The determination was carried out in 176 
supernatants of INS-1E cells. Absorbance was measured at 360 nm and carbonyl content was expressed 177 
as nmol/mg protein using an extinction coefficient of 22000 nmol/L/cm. Protein concentration was 178 
determined by the Bradford reagent. 179 
 180 
2.9. Statistics  181 
 10 
Prior to statistical analysis, the data were tested for homogeneity of variances using Levene test. 182 
For multiple comparisons, one-way ANOVA was followed by a Bonferroni test when variances were 183 
homogeneous or by the Tamhane test when variances were not homogeneous. The level of significance 184 
was p < 0.05. A SPSS version 22.0 program was used.  185 
 186 
187 
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3. Results and discussion 188 
3.1. Effects of CSE, CGA and CF on the redox status of cultured INS-1E cells  189 
 The aim of the present study was to obtain novel information regarding the mechanism of action 190 
of CSE and its bioactive components, CGA and CF, on the pathogenesis of diabetes induced by STZ. 191 
For this purpose, we used an established cell culture line from rats, INS-1E cells, which show important 192 
biological features of the pancreatic islet beta cells and have been widely used as a reliable model of 193 
beta cells.  194 
Doses of pure CGA and CF to be tested were selected taking into account the information on 195 
physiological concentrations reported by others. After normal dietary intakes, polyphenols and their 196 
metabolites appear in the circulatory system at nM-μM concentrations, so they are the most appropriate 197 
doses for in vitro studies (Rodriguez-Mateos et al., 2014). On the other hand, plasma concentrations 198 
may reach up to 10 μM of CF after the intake of a normal coffee serving (Martínez-López et al., 2014). 199 
The feasibility of the doses of CSE (1-10 µg/mL), CGA (1-10 µM) and CF (1-10 µM) for 200 
treating INS-1E was determined by the analysis of cellular redox status and antioxidant response 201 
biomarkers. Treatment of INS-1E with CSE, CGA and CF did not affect intracellular ROS generation 202 
or cell viability, indicating no cellular stress or damage (Table 1).  203 
Figure 1 shows that the treatment of INS-1E cells with CSE, CGA or CF preserved the GSH 204 
store (Figure 1A) and the GR activity (Figure 1C). Interestingly, CSE and the phenolic CGA evoked a 205 
significant increase (p < 0.05) in the enzymatic activity of GPx (Figure 1B). Glutathione and their 206 
related enzymes, GR and GPx, participate in the defence against hydrogen peroxides and superoxides 207 
and they are essential to prevent the cytotoxicity of ROS. Several phenolic compounds have shown to 208 
enhance the expression and activity of antioxidant enzymes in different tissues such as liver  (Martín et 209 
al., 2010; Sarriá et al., 2012) or colon (Rodríguez-Ramiro, Martín, Ramos, Bravo, & Goya, 2011) and 210 
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also in pancreatic beta cells (Martín, Fernández-Millán, Ramos, Bravo, & Goya, 2014). This outcome 211 
should have a significant impact on INS-1E cells because they are particularly susceptible to oxidative 212 
stress-induced injury due to the low-level expression of antioxidant enzymes as compared to other 213 
types of cells (Robertson, 2010). Furthermore, it has been demonstrated that the overexpression of 214 
antioxidant enzymes protects pancreatic beta cells from oxidative stress-induced dysfunction (Harmon 215 
et al., 2009). Therefore, the induction of GPx by CSE and CGA sets the cells in favourable conditions 216 
to face a potential oxidative challenge and could be an important strategy to improve beta cell survival 217 
in diabetes.  218 
 219 
3.2. CSE and CGA increased GSIS in INS-1E cells 220 
 Since the ineffectiveness of beta cells to secrete adequate amounts of insulin is decisive in the 221 
development and progression of T2D, agents that may improve beta cell function are considered key to 222 
prevent or to treat diabetes (Robertson, 2010). Accordingly, we were next interested in exploring the 223 
potential effect of CSE, CGA and CF on insulin secretory function. Indeed, it has been indicated that 224 
many phytochemicals present in plant foods, particularly polyphenols, could be able to induce insulin 225 
secretion in pancreatic beta cells (Huang et al., 2011; Kappel et al., 2013; Martín et al., 2014; 226 
Fernández-Millán et al., 2014).  227 
 After the incubation of INS-1E cells in the presence of CSE (1-10 µg/mL), CGA (1-10 µM) and 228 
CF (1-10 µM) for 20 hours, the GSIS was assayed for 90 min. As shown in Figure 2A-C, pre-treatment 229 
of cells with CSE and CGA, significantly increased (p < 0.05) insulin secretion in cells cultured in 230 
media containing 4 and 10 mM of glucose. However, CF resulted ineffective stimulating insulin 231 
secretion. According to that, a previous work reported a positive effect of CGA on insulin secretion 232 
(Tousch et al., 2008), besides the doses of CGA employed in that study were higher (28 and 140 µM) 233 
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than those tested in the present study. On the other hand, a very low concentration of CSE (1 µg/mL) 234 
resulted effective to increase insulin secretion in a glucose-dependent manner in pancreatic beta cells 235 
which is a novel and interesting result. This CSE dose contains 9.86 x 10-5µM of CGA which is lower 236 
than the effective doses of CGA (10 µM). These data suggest that other compounds are contributing to 237 
the observed effect. Synergistic effects of bioactive compounds present in the botanical matrix 238 
including those unknown can be responsible of the overall antidiabetic observed effect. Further studies 239 
should be conducted to identify such components of this particular extract contributing to the protective 240 
effect of pancreatic cells.  241 
The observed effect on insulin secretion could be due to an increase of insulin biosynthesis. To 242 
confirm this hypothesis, we also measured total insulin content in control and CSE, CGA, and CF 20 243 
hour-treated cells. As showed in Figure 2D, there was no difference in insulin levels between the 244 
control and treated INS-1E cells. Therefore, we can ensure that the augmented GSIS induced by CSE 245 
and CGA was not related to an increase in the biosynthesis of the hormone but rather to the stimulation 246 
of insulin secretion. In this regard, from a mechanistic point of view, several insulin secretagogues with 247 
recognized therapeutic effect such as sulfonylureas or glinides are able to close KATP channel and lead 248 
to an increase in glucose-induced depolarization. Consequently, voltage-dependent Ca2+ channels open, 249 
causing the acceleration of Ca2+ influx and the increase of the concentration of cytosolic free Ca2+ that 250 
is necessary and sufficient to trigger insulin secretion (Henquin, 2004). In line with this, it has been 251 
recently indicated that a coffee extract (100 µg/mL) and its main component CGA (28.2 µM ) may 252 
block KATP channel, conferring a regenerative effect on zebrafish pancreatic islet damaged with alloxan 253 
(Nam et al., 2015). On the contrary, Tousch et al., (2008) indicated that CGA at stimulating 254 
concentrations for insulin secretion (28.2 and 84.6 µM ) does not close KATP channels in rat INS-1E 255 
cells, suggesting that a different mechanism of action may be involved.  256 
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Other insulin secretagogues amplify Ca2+-induced insulin secretion though the activation of 257 
diverse protein kinases, including protein kinase A (PKA), protein kinase C (PKC) or extra cellular 258 
regulated kinases (ERKs), that are involved in the mechanism of insulin exocytosis itself (Bratanova-259 
Tochkova et al., 2002). Accordingly, several phenolic compounds such as quercetin (Youl et al., 2010) 260 
and microbial-derived flavonoid metabolites (Fernández-Millán et al., 2014) have demonstrated to 261 
increase glucose-stimulated insulin secretion via ERKs activation. Therefore, a potential role of the 262 
phenolic CGA on signalling pathways cannot be ruled out. Further studies about the molecular 263 
mechanisms involved in the action of CGA and CSE on beta cell insulin secretion are necessary.  264 
   265 
3.3. CSE and CGA protect INS-1E cells against STZ-induced oxidative stress 266 
 It is generally accepted that oxidative stress is involved in the loss of beta cell function and 267 
viability, thus, the protection of beta cells from oxidative stress is one of the mechanisms potentially 268 
involved in the prevention of diabetes (Bonora, 2008). Consequently, we finally investigated the 269 
protective effect of CSE, CGA and CF against oxidative stress. To this end, we used STZ, a chemical 270 
compound commonly used to induce diabetes through its toxic effects on pancreatic beta cells (Kim et 271 
al., 2003). The cytotoxic action of STZ is associated with the generation of ROS and the consequent 272 
beta cell destruction and suppression of insulin secretion (Szkudelski, 2001). 273 
Our first goal for this outcome was to determine the conditions leading to oxidative stress and 274 
cell death in INS-1E cells. Figure 3 reveals that increasing concentrations of STZ induced a dose-275 
dependent increase in ROS generation and cell toxicity as shown by the decrease in cell viability. Since 276 
the STZ concentration of 5 mM at 6 hours caused a significantly increase (p < 0.05) in ROS generation 277 
and nearly 40 % cell death (Figure 3), we decide to choose this concentration and that time for the 278 
following experiments.  279 
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 To investigate the potential of CSE, CGA and CF to protect beta cells against the impairment of 280 
viability or insulin secretion induced by STZ, we used effective doses of each compounds on antioxidant 281 
defence and insulin secretion. INS-1E cells were treated with 1 µg/mL CSE, 10 µM CGA or 10 µM CF 282 
during 20 hours  followed by treatment with 5 mM of STZ for 6 hours (for oxidative damage assays and 283 
cell viability) or for 90 minutes (for insulin secretion assays). Figure 4 illustrates the effect of the 284 
different treatments on the appearance of INS-1E cells. STZ treatment led to morphological changes 285 
such as cell shrinkage related to cell death. However, pre-treatment with CSE or CGA, but not CF, 286 
prevented these morphological alterations. In agreement with those data,  treatment of cells with STZ 287 
enhanced ROS generation (Figure 5A) and protein cell oxidative damage (measured as carbonyl groups) 288 
(Figure 5B) resulting in a remarkable decrease of INS-1E cell viability (Figure 5C). Pre-treatment with 289 
CSE or CGA significantly reduced (p < 0.05) the ROS over production  induced by STZ and prevented  290 
beta cell death. Since the increase in ROS generation induced by STZ has been directly implicated in 291 
pancreatic beta cell apoptosis (Zheng, et al., 2015; Bhakkiyalakshmi et al., 2014), it is reasonable to 292 
suggest that the effect of CGA and CSE reducing ROS over production possibly will contribute to 293 
reduce apoptosis and enhance cell survival of INS-1 beta cells. Likewise, STZ treatment also induced a 294 
significant decrease (p < 0.05) in insulin secretion in INS-1E cells (Figure 5d) whereas the pre-295 
incubation with CSE and CGA completely restored GSIS to control levels.  CF did not protect against 296 
oxidative stress, cell death or impaired insulin secretion induced by STZ. In parallel, the oxidative stress 297 
induced by STZ caused a significant decrease (p < 0.05) in GSH (Figure 6A) and a remarkable increase 298 
of GPx (Figure 6B) and GR (Figure 6C) activities in order to enhance the antioxidant cell defence 299 
against ROS. Under these extreme oxidative conditions pre-treatment of INS-1E cells with CSE and 300 
CGA greatly prevented GSH depletion and completely recovered GPx and GR activities. Altogether, 301 
our results indicate that the concentrations of CSE and CGA hereby assayed efficiently protect the 302 
 16 
viability and function of pancreatic beta cells against STZ while CF was ineffective on that since did not 303 
significantly inhibit ROS production.   304 
The cyto-protective effect of coffee and its phenolic components against an oxidative injury has 305 
previously been described in different cultured cells (Deng et al., 2013; Ahn et al., 2014; Baeza et al., 306 
2014). Results obtained for pure CGA are in line with those reporting a protective effect of different 307 
antioxidant compounds on pancreatic beta cells (Karunakaran & Park, 2013; Fernández-Millán et al., 308 
2014; Martín et al., 2014). However, the present study is the first to demonstrate a specific chemo-309 
protective effect of CSE on pancreatic beta cells. This effect produced by CSE cannot be ascribed to 310 
isolated CF or CGA, but to a synergic effect of different components present in the extract. Further 311 
studies are necessary to identify the compounds responsible for that property. On the other hand, our 312 
findings highlight the potential of CSE in the protection against diabetes supporting those described in 313 
the patented with number P201431848. 314 
  315 
316 
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4. Conclusion 317 
 In conclusion, for the first time we provide scientific evidences regarding the protective effects 318 
of CSE in pancreatic beta cells through its antioxidant actions and its ability to modulate insulin 319 
secretory function. In addition, our results suggest that physiological concentrations of pure CGA (10 320 
µM) are able to protect pancreatic cells against oxidative stress while CF in the same concentration is 321 
ineffective. On the other hand, since the concentrations of CGA present in CSE seems to be ineffective 322 
to protect pancreatic cells against diabetogenic agents causing cell oxidative stress (STZ), further 323 
research should be conducted to identify which compound/s are responsible for those benefits. Our 324 
findings support the potential of CSE as anti-diabetic phytodrug and functional ingredient for the 325 
prevention of diseases related to oxidative stress such as diabetes. Results also suggest that coffee by-326 
products present added value confirming that coffee is not only a drink.  327 
  328 
329 
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Figure captions 471 
Figure 1.- Effect of coffee silverskin extract (CSE), chlorogenic acid (CGA) and caffeine (CF) on GSH 472 
concentration and GPx and GR activities. C represents untreated control cells. INS-1E cells were 473 
treated with 1–10 μg/mL CSE and 1-10 μM of  CGA and CF for 20 h and GSH concentration (A) and 474 
GPx (B) and GR (C) activities were evaluated. Data represent means ± SD of 6-8 samples per 475 
condition. Different letters denote statistically significant differences, p < 0.05. 476 
 477 
 478 
 479 
 480 
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Figure 2.- Effect of coffee silverskin extract (CSE), chlorogenic acid (CGA) and caffeine (CF) on  481 
insulin secretion and insulin content in INS-1E cells. C represents untreated control cells. Cells were 482 
treated with 1–10 μg/mL CSE (A) and 1-10 μM CGA (B) and CF (C) for 20 h and then incubated in 483 
KRB medium containing 4 or 10 mM glucose for 90 min and insulin release was evaluated in the KRB 484 
medium. Insulin content was determined in non-treated control cells and in cells treated with CSE, 485 
CGA and CF for 20 h (D). Data represent means ± SD of 6-8 samples per condition. Different letters 486 
denote statistically significant differences, p < 0.05. 487 
 488 
 489 
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Figure 3.- Effect of streptozotocin (STZ) on ROS production and cell viability in INS-1E cells. Cells 490 
were treated with 1-5 mM STZ for 3, 6, 9 and 18 hours and ROS levels (A) and cell viability (B) were 491 
evaluated. Data represent means ± SD of 8-10 samples per condition. Different letters denote 492 
statistically significant differences, p < 0.05. 493 
 494 
 495 
 496 
 28 
Figure 4.- Representative microscopy images of INS-1 cells after different treatment. Untreated cells 497 
(C). Cells treated with 5 mM STZ for 6 h (STZ). Cells treated with 1 μg/mL CSE and further exposed 498 
to 5 mM STZ for 6 h (CSE + STZ). Cells treated with 10 μM of CGA and further exposed to 5 mM 499 
STZ for 6 h (CGA + STZ). Cells treated with 10 μM of CF for 20 h and further exposed to 5 mM STZ 500 
for 6 h (CF + STZ) 501 
 502 
 503 
 504 
 505 
 506 
 507 
 508 
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Figure 5.- Effect of coffee silverskin extract (CSE), chlorogenic acid (CGA) and caffeine (CF) against 509 
oxidative damage induced by STZ. C represents untreated control cells. Cells were treated with 1 510 
μg/mL CSE (A) and 10 μM of CGA (B) and CF (C) for 20 h and further exposed to 5 mM STZ for 6 h. 511 
Then, intracellular ROS generation (A), carbonyl group production (B) and cell viability (C) were 512 
measured. To evaluate cell functionality, after 20 h of CSE, CGA and CF treatment, control and treated 513 
cells were placed in KRB containing 10 mM glucose and 5 mM STZ and insulin secreted during 90 514 
min was evaluated (D). Data represent means ± SD of 8-10 samples per condition. Different letters 515 
denote statistically significant differences, p < 0.05. 516 
 517 
 518 
 519 
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Figure 6.- Effect of coffee silverskin extract (CSE), chlorogenic acid (CGA) and caffeine (CF) on GSH 520 
concentration and GPx and GR activity in STZ-treated cells. C represents untreated control cells. INS-521 
1E cells were treated with 1 μg/mL CSE (A) and 10 μM of CGA (B) and CF (C) for 20 h and further 522 
exposed to 5 mM STZ for 6 h. Then, GSH concentration (A) and GPx (B) and GR (C) activities were 523 
evaluated. Data represent means ± SD of 6-8 samples per condition. Different letters denote statistically 524 
significant differences, p < 0.05. 525 
526 
 31 
Table 1.- Effect of 20 hours treatment with noted concentrations of coffee silverskin extract (CSE), 527 
chlorogenic acid (CGA) and caffeine (CF) on cell viability and intracellular ROS generation in 528 
pancreatic INS-1E cells. C represents untreated control cells. Data represent means ± SD of 8-10 529 
samples per condition. Same letter a as superscript indicates that no significant differences were found, 530 
P < 0.05. 531 
 532 
 533 
 
 
  
% Cell Viability 
 
ROS  
(% Fluorescence Units) 
 
C 
  
100.3 ± 2.5a 
 
100.2 ± 6.3a 
 
CSE 
 
1 μg/mL 
 
103.4 ± 9.4a 
 
101.2 ± 6.4a 
 
 
 
5 μg/mL 
 
104.2 ± 4.4a 
 
99.8 ± 7.2a 
 
 
 
10 μg/mL 
 
102.1 ± 4.6a 
 
100.2 ± 8.7a 
 
CGA 
 
1 μM 
 
99.8 ± 5.4a 
 
97.4 ± 82a 
 
 
 
5 μM 
 
98.9 ± 8.7a 
 
100.3 ± 9.2a 
 
 
 
10 μM 
 
98.7 ± 7.7a 
 
101.2 ± 5.8a 
 
CF 
 
1 μM 
 
100.3 ± 5.8a 
 
99.7 ± 5.8a 
 
 
 
5 μM 
 
102.4 ± 4.0a 
 
96.8 ± 8.8a 
 
 
 
10 μM 
 
100.4 ± 2.0a 
 
97.3 ± 9.3a 
